AtaiBeckley Inc. ATAI

Updated: 17 Jun 2026

NASDAQ | Biotech | Mental health biopharmaceuticals

No signal published yet

We already track AtaiBeckley and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow AtaiBeckley free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Mental health biopharmaceuticals
We're already tracking AtaiBeckley Inc. — here are the latest events we've registered

Recent News

  • In June 2026, AtaiBeckley presented updates on its Phase 3 ReConnection program for BPL-003, an intranasal treatment for depression. The company also recently reported positive Phase 2a results for its social anxiety disorder candidate, EMP-01.

What Firelda Watch includes for AtaiBeckley Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of AtaiBeckley Inc. will be delivered in the same format.

Want to follow AtaiBeckley Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow AtaiBeckley free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

AtaiBeckley Inc. ATAI
AtaiBeckley — follow and we'll monitor it
Follow AtaiBeckley free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.